The same drug development news that's hurting Eli Lilly shares might be good for Amgen and Sanofi-Regeneron.» Read More
Countries that spend much less on health care tend to see better overall health outcomes than the U.S.
CareDx warns it won't be able to sell its transplant rejection test if a proposed Medicare reimbursement cut goes through.
The "hold harmless" provision in the law that addresses cost-of-living adjustments (COLA) for Social Security benefits is to blame.
Drugmaker Roche said its experimental medicine for multiple sclerosis performed better in a late-stage clinical trial than a commonly used therapy.
Childhood obesity is a major epidemic and the government can save billions by helping to fight it in this way, says Curt Ellis.
Oncologists, aware that patients are paying the costs of expensive cancer drugs, are declining to prescribe medicines that have scant or no effect.
Indonesia's president said on Thursday that he had asked Singapore, Russia, Malaysia and Japan for help to put out forest fires.
As a joint federal-state program serving the poor, Medicaid stands on narrower, shakier ground. That's especially true in the GOP presidential race.
Express Scripts, the largest pharmacy benefits manager in the U.S., says it's got a plan to fight drug price increases: Refuse to pay.
Overall, people spent more than two hours on the average doctor's visit, which means they spent two hours not doing work.
#1 biotech and pharma stock picks
The nation's largest pharmacy benefit manager plans to control costs from new cholesterol drugs through discounts and restricting use.
Three scientists have shared the Nobel Prize for medicine for work on key drugs used to fight parasitic diseases, the FT reports.
U.S. biotech shares extended their downward spiral on Tuesday as concerns about drug pricing continued to plague the sector.
There was a drop in the number of patients seen by doctors, who still had increased payments.
Spark Therapeutics plans to file for U.S. regulatory approval next year for the first gene therapy product on the market in the U.S.
MSF is leaving Kunduz after an airstrike on its hospital there on Saturday that killed 22 people, the NYT reports.
Morgan Stanley analyzed the drug pricing issue and found which companies are the best and worst positioned in a note sent to clients on Thursday.
Many companies at risk of the tax on high-cost health plans intend to avoid the levy.
After a string of young soccer players fall ill, June Leahy searches for answers on turf that could have caused her daughter's death, says NBC News
Get the best of CNBC in your inbox